This inventor holds 3 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Warszawski Uniwersytet Medyczny, Instytut Farmaceutyczny, Zaklady Farmaceutyczne Polpharma S.a.. Active years: 2013-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 12 
1 out of 10 
1 out of 8 Years Active: 2013-2019
Title: Marta Laszcz: Innovator in Pharmaceutical Chemistry
Introduction
Marta Laszcz, an accomplished inventor based in Warsaw, Poland, has made significant contributions in the field of pharmaceutical chemistry. With a total of three patents to her name, she continues to push the boundaries of scientific research and development, particularly in pharmacological applications.
Latest Patents
Among her latest innovations are two notable patents that focus on the compound protoescigenin. The first patent describes a protoescigenin derivative, outlining a process for its preparation and its pharmaceutical applications, especially in treating vascular disorders. This invention highlights the compound's pharmacological properties and its potential as a medicament. The second patent details a comprehensive process for obtaining protoescigenin through hydrolysis of escin. This method involves a two-step hydrolysis under acidic and basic conditions, followed by enrichment and purification steps to yield high-purity protoescigenin. Additionally, it includes the crystallization of protoescigenin monohydrate, demonstrating its versatility as a synthon for further chemical modifications.
Career Highlights
Marta has worked with esteemed institutions such as the Medical University of Warsaw and the Pharmaceutical Institute. Her tenure at these organizations has not only advanced her personal career but also contributed significantly to ongoing research projects that explore innovative treatments in the pharmaceutical landscape.
Collaborations
Throughout her career, Marta has collaborated with prominent individuals like Oliwia Zegrocka-Stendel and Grzegorz Grynkiewicz. These partnerships underscore the importance of teamwork in scientific innovation, allowing for diverse insights and enhanced research outcomes.
Conclusion
Marta Laszcz stands out as a pioneering inventor in the realm of pharmaceutical chemistry. Her innovative work with protoescigenin derivatives has the potential to revolutionize treatment methods for vascular disorders. As she continues her research, her contributions promise to inspire future generations of scientists and innovators in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile